Navigation Links
Procter & Gamble Announces Organizational Changes
Date:1/15/2009

CINCINNATI, Jan. 15, 2009 /PRNewswire-FirstCall/ -- The Procter & Gamble Company (NYSE: PG) today announced the following organizational changes:

-- Mariano Martin, (56), global customer business development officer, will retire effective June 30, 2009, after 33 years of service. He will step down from his current role on February 1, 2009, when he will focus on working closely with his successor to ensure a smooth transition with P&G's retail customers and global customer business development organization.

-- Robert L. Fregolle, Jr., (51), currently vice president of customer business development for P&G Asia, has been named global customer business development officer, effective February 1, 2009, reporting to Werner Geissler, vice chairman - global operations.

    (Logo: http://www.newscom.com/cgi-bin/prnh/20090115/CLTH035LOGO-a )
    (Photo:http://www.newscom.com/cgi-bin/prnh/20090115/CLTH035-b )
    (Photo:http://www.newscom.com/cgi-bin/prnh/20090115/CLTH035-c )
    (Photo:http://www.newscom.com/cgi-bin/prnh/20090115/CLTH035-d )
    (Photo:http://www.newscom.com/cgi-bin/prnh/20090115/CLTH035-e )

"Mariano's vision and leadership has enabled P&G to become a strong partner and preferred supplier to retail customers around the world," said P&G Chairman of the Board and Chief Executive Officer A.G. Lafley. "He's worked closely with leading retailers to create joint value and establish new ways of working together. He's delivered P&G brands to more of the world's consumers by expanding distribution to new retail channels and millions of high-frequency stores. And he's strengthened the capabilities of our Global Customer Business Development organization."

On Fregolle's appointment, Lafley said, "Bob has been part of P&G's Customer Business Development leadership for more than a decade. He's worked in developed and developing markets and global and regional businesses, and has partnered with large retailers, distributors and high-frequency stores. Most recently, as Vice President - Customer Business Development, Asia, Bob initiated the transition to a single CBD organization focused on leveraging P&G's scale to reach millions of Asian consumers. He has the diverse, global experience to continue to strengthen our customer relationships in this challenging business environment and beyond."

About Procter & Gamble

Three billion times a day, P&G brands touch the lives of people around the world. The company has one of the strongest portfolios of trusted, quality, leadership brands, including Pampers(R), Tide(R), Ariel(R), Always(R), Whisper(R), Pantene(R), Mach3(R), Bounty(R), Dawn(R), Gain(R), Pringles(R), Charmin(R), Downy(R), Lenor(R), Iams(R), Crest(R), Oral-B(R), Actonel(R), Duracell(R), Olay(R), Head & Shoulders(R), Wella(R), Gillette(R), Braun(R) and Fusion(R). The P&G community includes approximately 138,000 employees working in over 80 countries worldwide. Please visit http://www.pg.com for the latest news and in-depth information about P&G and its brands.


'/>"/>
SOURCE The Procter & Gamble Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Procter & Gamble Reaches Settlement on Patent Infringement Lawsuit
2. Procter & Gambles Live, Learn and Thrive Donates $200,000 to Feeding America in an Effort to Fight Child Hunger in America
3. Wyeth Consumer Healthcare Signs Agreement to Purchase ThermaCare from Procter & Gamble
4. Procter & Gamble Confirms Prior Sales and Earnings Guidance for Fourth Quarter 2007/08
5. Procter & Gamble Announces Board Changes
6. New Water Purification Product from Reliance Products and Procter & Gamble now Available in Retail Stores
7. Procter & Gamble Announces Organizational Changes
8. Procter & Gamble Announces Appointment of Director
9. Procter & Gamble Files Infringement Lawsuit
10. Procter & Gamble Products Help Raise Funds, Awareness in Fight Against Childhood Cancer
11. ACG Announces Generous Gift by Procter & Gamble
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... ... December 05, 2016 , ... The ... care facility – Avamere Transitional Care of Puget Sound ; located at ... health care center will provide patients recovering from illness or injury with intensive ...
(Date:12/5/2016)... VA (PRWEB) , ... December 05, 2016 , ... ... today announced it has been featured in SuperbCrew magazine, a leading online tech ... tech world. This interview, now featured on SuperbCrew.com, explores the state of enterprise ...
(Date:12/5/2016)... ... ... Researchers at Johns Hopkins All Children’s Hospital want to learn more about ... of three years, researchers will study concussions and changes in brain function by monitoring ... sensors, will track the location and force of the hit. The sensors store data ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Epilepsy ... through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on the ... 26 people will be diagnosed with epilepsy within their lifetime. With such a ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Sanovas, Inc., a life science asset holding ... its wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed ... - http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed ...
(Date:12/5/2016)... 2016  CVS Health, the nation,s largest pharmacy innovation ... score of 100 percent on the Corporate Equality Index ... an annual national benchmarking survey and report on corporate ... the Human Rights Campaign Foundation. "Our ... colleagues, customers and suppliers bring to CVS Health," said ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 /PRNewswire/ ... announced preliminary safety and efficacy data from a ... selective MDM2 inhibitor, suggesting that DS-3032 may be ... acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome ... of the phase 1 study of DS-3032 were presented ...
Breaking Medicine Technology: